All AbMole products are for research use only, cannot be used for human consumption.
SSR128129E is an orally-active and allosteric FGFR1 inhibitor with IC50 of 1.9 μM, while not affecting other related RTKs.
 |
Source | PLoS One (2013). Figure 3. SSR128129E |
| Method | qPCR | |
| Cell Lines | C57BL/6 | |
| Concentrations | 50 mg/kg/d | |
| Incubation Time | - | |
| Results | Treatment of apoE-deficient mice with SSR128129E did not affect the mRNA levels of all the receptors but FGFR2, the levels of which were slightly, but significantly, reduced |
| Cell Experiment | |
|---|---|
| Cell lines | Endothelial cells (ECs) and Panc02 tumor cells |
| Preparation method | Cell proliferation of porcine aortic endothelial (PAE) and tumor cell lines is analyzed on exponentially growing cells that are starved for 16 hours in 0.2 % FBS containing medium and seeded at 4,000 cells/well in 96-well microplates. After exposure to mitogens and/or SSR for 72 hours, according to manufacturer’s instructions, assessing the cell proliferation with the use of the CellTiter 96 AQueous One Solution Cell Proliferation Assay . 10 % FBS containing medium is used a positive control |
| Concentrations | ~100 nM |
| Incubation time | 72 hours |
| Animal Experiment | |
|---|---|
| Animal models | Mouse model of Arthritic and mouse tumor model bearing pancreatic tumor cell line Panc02, murine mammary carcinoma cell line 4T1, murine colon cancer cell line CT26, or human breast MCF7/ADR cell line. |
| Formulation | 0.6 % methylcellulose |
| Dosages | ~30 mg/kg |
| Administration | Oral administration |
| Molecular Weight | 346.31 |
| Formula | C18H15N2O4.Na |
| CAS Number | 848318-25-2 |
| Solubility (25°C) | DMSO 50 mg/mL |
| Storage |
Powder -20°C 3 years ; 4°C 2 years In solvent -80°C 6 months ; -20°C 1 month |
| Related FGFR Products |
|---|
| AZD4547
AZD4547 (Fexagratinib) is a potent, selective and orally active pan-FGFR inhibitor with IC50s of 0.2. 2.5, 1.8 and 165 nM for FGFR1, 2, 3 and 4, respectively. |
| BGJ398 (Infigratinib)
BGJ398 (Infigratinib) is a potent and selective FGFR kinase inhibitor with IC50 values of 0.9 nM, 1.4 nM, 1 nM and 60 nM for FGFR1, FGFR2, FGFR3 and FGFR4, respectively. |
| PD173074
PD173074 is a selective FGFR1 and FGFR3 inhibitor with IC50 values of 5, 21.5, ~100, 17600 and 19800 nM for FGFR3, FGFR1, VEGFR2, PDGFR and c-Src respectively. |
| LY2874455
LY2874455 is a novel and potent FGF/FGFR inhibitor. |
| SKLB610
SKLB610 is a novel potential inhibitor of vascular endothelial growth factor receptor tyrosine kinases inhibits angiogenesis and tumor growth in vivo. |
All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.
